サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541032

創薬インフォマティクス市場レポート：ワークフロー、機能、モード、エンドユーザー、地域別、2024～2032年

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
創薬インフォマティクス市場レポート：ワークフロー、機能、モード、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬インフォマティクス市場規模は2023年に33億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに78億米ドルに達し、2024～2032年の間に9.7％の成長率（CAGR）を示すと予測しています。

創薬インフォマティクスは、大量の生化学データの分析と解釈に使用される技術ソリューションです。データは、研究目的で臨床試験室で実施された実験から生成され、様々な医薬品の開発に関する洞察を得るために利用されます。シーケンシング、対象データ解析、データ可視化、ドッキング、分子モデリング、創薬開発のためのデータベース保護など、多くのソフトウェアやハードウェアベースのツールが含まれます。その結果、医療機関、製薬・バイオテクノロジー機関、CRO（医薬品開発業務受託機関）などで広く利用されています。

世界中の医療と製薬業界の著しい成長は、市場の明るい展望を生み出す主要要因の1つです。さらに、慢性疾患の有病率の増加や、希少疾患を治療するための効果的なソリューションに対する要求の高まりも、市場の成長を後押ししています。創薬インフォマティクスは、新薬の分析や複数の情報源からの生物学的情報の取り扱いに、製薬企業によって広く利用されています。さらに、モデリングとシミュレーションを通じて薬剤動態学的結果の予測を支援する革新的な生理学的薬剤動態（PBPK）シミュレータプラットフォームの開発など、さまざまな技術的進歩も成長を促す要因となっています。これに伴い、オーファンドラッグ開発のための政府や民間医療機関による投資の増加も市場成長に寄与しています。その他の要因としては、高齢者人口の増加、バイオインフォマティクスセグメントにおける広範な研究開発（R&D）活動などがあり、市場のさらなる牽引役となると予想されます。

本レポートで扱う主要質問

  • 世界の創薬インフォマティクス市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が世界の創薬インフォマティクス市場に与えた影響は？
  • 主要地域市場とは？
  • ワークフロー別の市場内訳は？
  • 機能別の市場内訳は？
  • モード別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の創薬インフォマティクス市場の構造と主要参入企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の創薬インフォマティクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：ワークフロー別

  • 創薬
  • 医薬品開発

第7章 市場内訳：機能別

  • 配列解析プラットフォーム
  • 分子モデリング
  • 分子ドッキング
  • 臨床試験データ管理
  • その他

第8章 市場内訳：モード別

  • アウトソーシング
  • 社内

第9章 市場内訳：エンドユーザー別

  • 製薬会社
  • バイオテクノロジー企業
  • 研究機関（CRO）
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2023
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2023
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2023
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2024-2032
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2024-2032
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2024-2032
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players
目次
Product Code: SR112024A3515

The global drug discovery informatics market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global drug discovery informatics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

Drug Discovery

Drug Development

Breakup by Function:

Sequence Analysis Platforms

Molecular Modelling

Molecular Docking

Clinical Trial Data Management

Others

Breakup by Mode:

Outsourced

In-house

Breakup by End User:

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organization (CROs)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug discovery informatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug discovery informatics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis